Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) Total Inventories : HK$447 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Yichang HEC ChangJiang Pharmaceutical Co Total Inventories?

Yichang HEC ChangJiang Pharmaceutical Co's total inventories for the quarter that ended in Dec. 2023 was HK$447 Mil. Yichang HEC ChangJiang Pharmaceutical Co's average total inventories from the quarter that ended in Jun. 2023 to the quarter that ended in Dec. 2023 was HK$417 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Yichang HEC ChangJiang Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$-1.78.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Yichang HEC ChangJiang Pharmaceutical Co's Days Inventory for the six months ended in Dec. 2023 was 104.84.

Inventory Turnover measures how fast the company turns over its inventory within a year. Yichang HEC ChangJiang Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.74.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Yichang HEC ChangJiang Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.12.

Yichang HEC ChangJiang Pharmaceutical Co Total Inventories Historical Data

The historical data trend for Yichang HEC ChangJiang Pharmaceutical Co's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yichang HEC ChangJiang Pharmaceutical Co Total Inventories Chart

Yichang HEC ChangJiang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

214.01

448.41

342.48

351.80

447.41

Yichang HEC ChangJiang Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Inventories	Get a 7-Day Free Trial														342.48	369.62	351.80	386.70	447.41

Yichang HEC ChangJiang Pharmaceutical Co Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Yichang HEC ChangJiang Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1831.438	+	0.75 * 2188.167	+	0.5 * 447.41	-	5259.781
-	0	-	0)	/	879.968
=	-1.78

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Yichang HEC ChangJiang Pharmaceutical Co's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	417.0555	/	726.003	*	365 / 2
	=	104.84

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Yichang HEC ChangJiang Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	726.003	/	417.0555
	=	1.74

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Yichang HEC ChangJiang Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	417.0555	/	3374.946
	=	0.12

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Yichang HEC ChangJiang Pharmaceutical Co Total Inventories Related Terms

Thank you for viewing the detailed overview of Yichang HEC ChangJiang Pharmaceutical Co's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yichang HEC ChangJiang Pharmaceutical Co Ltd (HKSE:01558) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

No. 38 Binjiang Road, Yidu, Hubei Province, Yichang, CHN

Website

http://www.hec-changjiang.com

Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product, Kewei. It is one of the leading products in China's anti-influenza market. Its other products include Ertongshu, Oumeining, Olmesartan Tablets, and Clarithromycin Tablets.

Executives

Shao Guan Xin Yu Neng Shi Ye Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Xiang Gang Dong Yang Guang Xiao Shou You Xian Gong Si	2101 Beneficial owner
Shen Zhen Shi Dong Yang Guang Shi Ye Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Dong Dong Yang Guang Yao Ye Gu Fen You Xian Gong Si	2101 Beneficial owner
Ru Yuan Yao Zu Zi Zhi Xian Xin Jing Ke Ji Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Ru Yuan Yao Zu Zi Zhi Xian Yu Neng Dian Zi Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you
Guo Meilan	2201 Interest of corporation controlled by you
Hua Xiaoyi	2201 Interest of corporation controlled by you
Zhang Yushuai	2201 Interest of corporation controlled by you
Blackstone Dawn Pte. Ltd.	2101 Beneficial owner
Blackstone Tactical Opportunities Management Associates (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Inc.	2201 Interest of corporation controlled by you
Btof (dawn Feeder) (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Tactical Opportunities Management Associates Iii (cayman) – Nq L.p.	2201 Interest of corporation controlled by you
Blackstone Tactical Opportunities Lr Associates (cayman) – Nq Ltd.	2201 Interest of corporation controlled by you

Yichang HEC ChangJiang Pharmaceutical Co (HKSE:01558) Headlines

No Headlines